Turkey Events Eurasia Biotechnology Forum Agenda

14:00 – 14:05        Welcome Remarks
Heather Byrnes, Regional Senior Commercial Officer Eurasia
U.S. Commercial Service, U.S. Department of Commerce

14:05 – 14:15        Keynote Speaker
Lawrence C. Brody, Ph.D., Director, Division of Genomics and Society, National Institutes of Health (NIH)

14:15 – 15:00         Risks in Biotechnology: The Need to Protect Health Data
The accumulation of vast amounts of population-wide healthcare data allows adversaries to identify and target vulnerabilities in certain populations that may then be exploited for political gain. 
Edward H. You, Supervisory Special Agent for Emerging and Disruptive Technologies, Federal Bureau of Investigation (FBI)

15:00 – 15:45         Safely Developing National Biotech Ecosystems
As the biotechnology sector grows, countries in Eurasia must consider how to develop their own advanced healthcare ecosystems to best serve their populations. For many countries, the proliferation of diagnostics labs as a consequence of the COVID-19 pandemic have underscored the need for oversight of sensitive personal healthcare data.
Participants:
-    Matt McMahon, PhD, Director, SEED Office, National Institutes of Health (NIH)
-    ‪Rabia Çakır Koç, PhD, Director, Türkiye Biotechnology Institute, Health Institutes of Türkiye (TUSEB) ‬‬
-    Burcu Yücel, PhD, Director, Türkiye Cancer Institute, Health Institutes of Türkiye (TUSEB) 

15:45 – 16:45        Presentations on the Use of Next Generation Sequencing
What is Next Generation Sequencing (NGS)? How is it used to diagnose diseases? How do companies employ this technology, and what products are available for government health care programs looking to ensure the wellbeing and safety of their populations?
Presenters: 
-    Maroun Boutros, PhD, Senior Manager, Medical Affairs, EMEA, Illumina 
-    Sarah Chahine, PhD, Emerging Markets Sales Leader, Clinical Sequencing Business, Thermo Fisher Scientific 
-    Neil Ward, Vice President and General Manager, EMEA, Pacific Biosciences  

16:45 – 17:15        Genetic Diagnostic Labs: The Value of Trusted Partners
Markets lacking the infrastructure/capacity to develop their own biotechnology sectors rely on laboratories abroad to process genetic data for diagnostics purposes. Genetics laboratories in the United States and Turkey offer safe, reliable services.
Presenters:
-    Sonya Jaferey, International Regional Sales Director Laboratory Corporation of America (Labcorp) 
-    Joseph Kelly, Sr. Director, Genomic Sequencing Services, Quest Diagnostics
-    Ryan Serra, Sr. Director, Genomic Sequencing Services, Quest Diagnostics

17:15 – 17:20        Closing Remarks 
Heather Byrnes, Regional Senior Commercial Officer Eurasia
U.S. Commercial Service, U.S. Department of Commerce